Edition:
United States

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

4.10USD
8 Dec 2017
Change (% chg)

$0.09 (+2.24%)
Prev Close
$4.01
Open
$4.03
Day's High
$4.15
Day's Low
$3.99
Volume
32,893
Avg. Vol
69,867
52-wk High
$9.40
52-wk Low
$1.84

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.17 December 11 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.75 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 10.75 13.75 9.50 0.00
Quarter Ending Mar-18 1 9.50 9.50 9.50 --
Year Ending Dec-17 4 39.75 50.01 36.07 3.33
Year Ending Dec-18 4 58.51 116.00 32.75 6.67
Earnings (per share)
Quarter Ending Dec-17 4 -0.17 -0.12 -0.26 -0.31
Quarter Ending Mar-18 1 -0.16 -0.16 -0.16 --
Year Ending Dec-17 4 -0.65 -0.60 -0.73 -1.25
Year Ending Dec-18 4 0.62 2.24 -0.89 -1.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 16.06 9.56 6.50 40.46
Quarter Ending Jun-17 7.75 10.01 2.26 29.16
Quarter Ending Mar-17 5.31 7.00 1.68 31.70
Quarter Ending Dec-16 1.67 0.80 0.87 52.06
Quarter Ending Sep-16 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-17 -0.05 -0.13 0.08 -178.37
Quarter Ending Jun-17 -0.17 -0.19 0.02 -15.15
Quarter Ending Mar-17 -0.22 -0.14 0.08 -35.96
Quarter Ending Dec-16 -0.26 -0.35 0.09 -33.89
Quarter Ending Sep-16 -0.34 -0.31 0.03 -7.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 10.75 10.75 10.75 14.55 0.00
Quarter Ending Mar-18 9.50 9.50 9.50 -- --
Year Ending Dec-17 39.75 39.75 39.75 47.66 3.33
Year Ending Dec-18 58.51 58.51 58.51 74.20 6.67
Earnings (per share)
Quarter Ending Dec-17 -0.17 -0.17 -0.17 -0.15 -0.31
Quarter Ending Mar-18 -0.16 -0.16 -0.16 -- --
Year Ending Dec-17 -0.65 -0.65 -0.65 -0.53 -1.25
Year Ending Dec-18 0.62 0.62 0.62 0.70 -1.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0